NSECredit Rating11 Sept 2026 · 11 Sept 2026, 02:32 pm

Credit Rating

Zydus Lifesciences Limited · ZYDUSLIFE

✦ AI SummaryRating Change

Zydus Lifesciences Limited has informed the Exchange about Credit Rating, with CRISIL Ratings Limited reaffirming the credit ratings of various instruments/facilities of the Company.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Zydus Lifesciences Limited has informed the Exchange about Credit Rating

Attachments (1)

📄

Cadilahc_11092026143115_SEIntimationcreditrating11092026.pdf

pdf

Download →
View document text
September 11, 2026 Listing Department Code: 532321 Listing Department Code: ZYDUSLIFE BOMBAY STOCK EXCHANGE LIMITED NATIONAL STOCK EXCHANGE OF INDIA LIMITED P J Towers, Dalal Street, Fort, Exchange Plaza, Bandra Kurla Complex, Mumbai–400 001 Bandra (E), Mumbai–400 051 Re.: Intimation of Credit Rating pursuant to the provisions of regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”) and SEBI Master Circular dated January 30, 2026 (“SEBI Circular”) Dear Sir / Madam, Pursuant to the provisions of regulation 30 of the Listing Regulations, we would like to inform that CRISIL Ratings Limited vide their letters all dated September 10, 2026, reviewed and reaffirmed the credit ratings of various instruments / funds facilities of the Company, as per below details: Sr. Facility / Instrument Amount Ratings No. (Rs. in Cr.) 1. Various Bank 4,724 Long term rating CRISIL AAA/Stable (Reaffirmed) Facilities Short term rating CRISIL A1+ (Reaffirmed) 2. Commercial Papers 200 CRISIL A1+ (Reaffirmed) (CPs) * 3. Non-Convertible 50 CRISIL AAA/Stable (Reaffirmed) 4. Debentures (NCDs) * 75 CRISIL AAA/Stable (Reaffirmed) * There are no outstanding CPs / NCDs as on date. The credit rating letter along with rationale is enclosed herewith. Please bring the aforesaid news to the notice of the members of the exchange and the investors at large. Thanking you, Yours faithfully, For, ZYDUS LIFESCIENCES LIMITED DHAVAL N. SONI COMPANY SECRETARY AND COMPLIANCE OFFICER MEMBERSHIP NO. FCS7063 Encl.: As above